Furthermore, significantly higher concentrations of ATG13 were identified in the kidneys of the CIS-treated Gal-3 KO mice compared to the CIS-treated Gal-3 wild-type mice, with statistical significance (p < 0.001) (Figure 10A). The gene discussed is ATG13; the disease is in situ carcinoma.